Edwards Lifesciences EW Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's accounts receivable?
- Edwards Lifesciences (EW) reported accounts receivable of $775.7M in Q1 2026.
- How has Edwards Lifesciences's accounts receivable changed year-over-year?
- Edwards Lifesciences's accounts receivable increased by 15.9% year-over-year, from $669.2M to $775.7M.
- What is the long-term trend for Edwards Lifesciences's accounts receivable?
- Over 5 years (2020 to 2025), Edwards Lifesciences's accounts receivable has grown at a 5.1% compound annual growth rate (CAGR), from $514.6M to $659.6M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.